Top Markets
#1 Islamic Coin Islamic Coin +155.94%
#2 Siren Siren +37.74%
#3 Verus Coin Verus Coin +21.37%
#4 Arowana Arowana +18.32%
#5 Cysic Cysic +15.27%
#6 Perle Perle +14.96%
#7 OpenEden OpenEden +14.29%
#8 KUB Coin KUB Coin +12.04%
#9 RedStone RedStone +11.91%
#10 Geodnet Geodnet +9.47%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Advanced Biomed Inc. Common Stock Advanced Biomed Inc. Common Stock

Advanced Biomed Inc. Common Stock

ADVB
Classement en actions #31829
Advanced Biomed Inc. functions as an investment holding company, primarily... Advanced Biomed Inc. functions as an investment holding company, primarily dedicated to the research and development of microfluidic biochip technologies. Based in Taiwan, the company leverages these innovations to enhance precision oncology, spanning cancer detection, diagnosis, and treatment. Its diverse product portfolio includes a suite of advanced devices: A+Pre: A fully automated system designed for pre-concentrating diluted blood samples. AC-1000: A rare cell device engineered to address the challenges of detecting cells in hypercoagulable samples from tumor patients. A+SCDrop: A specialized tool for capturing individual circulating tumor cells (CTCs). A+CellScan: An analyzer featuring an immunostaining chip, utilized for the immunostaining and analysis of output from the AC-1000. Beyond standalone devices, Advanced Biomed provides microfluidic biochips, including the A+Pre, AC-1000 CTC Enrichment, and A+CellScan chips, which are integral to delivering assay products and services to cancer patients. The company also offers a comprehensive range of immunochromogenic kits: A+CTCE kit: Used to identify epithelial circulating tumor cells by detecting EpCAM, CK (pan), CD45, and CD14 antibodies. A+CTCM kit: Targets mesenchymal circulating tumor cells through their expression of Vimentin, CD45, and CD14 antibodies. A+EMT kit: Designed for the identification of epithelial-to-mesenchymal circulating tumor cells, focusing on cell-surface Vimentin, CD45, and CD14 antibodies. A+CM kit: Facilitates the detection of tumor-associated macrophages by assessing PD-L1, CD45, and CD14 antibodies. In addition to its current offerings, Advanced Biomed is actively developing A+LCGuard, a promising solution for the early screening of lung cancer. The company further expands its presence by establishing and operating medical clinics in the People's Republic of China. Founded in 2014, Advanced Biomed Inc. maintains its corporate headquarters in New York, New York.
Prix de l'action
$8.65
Dernière synchronisation: 2026-08-17
Capitalisation boursière
$11.96M
Changement (1 jour)
-3.35%
Changement (1 an)
2.98%
Pays
US
Échange Advanced Biomed Inc. Common Stock (ADVB)

Catégorie

Healthcare
Nombre d'actions en circulation pour Advanced Biomed Inc. Common Stock (ADVB)
Nombre d'actions en circulation au August 2026: 0
Selon les derniers rapports financiers et le cours de l'action de Advanced Biomed Inc. Common Stock, le nombre actuel d'actions en circulation est de 0. À la fin de August 2026, l'entreprise avait 0 actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Advanced Biomed Inc. Common Stock (ADVB) de 2026 à 2026
Actions en circulation à la fin de chaque année
Année Actions en circulation Changez
Pas assez de données pour les dates fournies.
Actions en circulation pour des entreprises similaires ou concurrentes
Entreprise Actions en circulation Différence Pays
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 371.00M -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 705.30M -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 143.28M -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 80.10M -
US